No Improvement of Patient or Graft Survival in Transplant Recipients Treated with Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers: A Collaborative Transplant Study Report-Reference-Cited by-同舟云学术

No Improvement of Patient or Graft Survival in Transplant Recipients Treated with Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers: A Collaborative Transplant Study Report

Published:2006-10-11 Issue:11 Volume:17 Page:3257-3262
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Opelz Gerhard,Zeier Martin,Laux Gunter,Morath Christian,Döhler Bernd

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference11 articles.

1. Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Type 1 Receptor Antagonist Therapy Is Associated with Prolonged Patient and Graft Survival after Renal Transplantation

2. Collaborative Transplant Study, University of Heidelberg, Germany. Available at: www.ctstransplant.org. Accessed May 30, 2006

3. Association of chronic kidney graft failure with recipient blood pressure

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of proteinuria after living donor kidney transplantation and related risk factors: A retrospective cohort study from Syria;Transplantation Reports;2024-09

2. Bridging the Gap Between CKD Management Paradigms in Transplant and Nontransplant Settings: Published Evidence, Challenges, and Perspectives;Transplantation;2024-08-29

3. Kardiovaskuläre Abklärung vor Listung und kardiovaskuläres Risikomanagement nach Transplantation;Die Nephrologie;2024-01-04

4. Hypertension in pediatric kidney transplantation;Pediatric Transplantation;2023-04-28

5. Arterial hypertension in kidney transplantation: huge importance, but few answers;Brazilian Journal of Nephrology;2023-03